Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206-Reference-Cited by-同舟云学术

Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206

Published:2013-01 Issue:1 Volume:8 Page:102-108
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kelley Michael J.,Bogart Jeffrey A.,Hodgson Lydia. D.,Ansari Rafat H.,Atkins James N.,Pang Herbert,Green Mark R.,Vokes Everett E.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

2. Small cell lung cancer: past, present, and future;Rodriguez;Curr Oncol Rep,2010

3. Clinical pharmacokinetics of irinotecan;Chabot;Clin Pharmacokinet,1997

4. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer;Masuda;J Clin Oncol,1992

5. llabJapan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N Engl J Med,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Dose/Fractionation Debate in Limited-Stage Small Cell Lung Cancer;Cancers;2024-05-17

2. Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers;Current Oncology;2024-03-20

3. Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data;Cancers;2022-12-31

4. Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-01-28

5. Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial;International Journal of Radiation Oncology*Biology*Physics;2021-10